Skip to content

Author

S. Arulsamy

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

BreastCAR: A Machine Learning Framework for Breast Cancer Drug Activity Prediction.

Breast cancer is a highly prevalent and molecularly heterogeneous malignancy, where therapeutic resistance and off-target toxicity remain major challenges. Here, we introduce BreastCAR, a multi-target quantitative structure-activity relationship framework trained on ChEMBL bioactivity data covering 53 cancer-relevant t...

Stalin Arulsamy, D. Ramesh, Vanktesh Kumar et al. · 0 citations
Oct 2026

Decoding the Molecular Target Landscape of Chalcones: An Integrated Cheminformatics Analysis Using PubChem Patent Data, Protein Target Profiling, and Bioassay Activity Mapping.

Chalcones represent a tractable, polypharmacological scaffold with target engagement validated across 145 human proteins, and hit-rate patterns provide reliable evidence even after accounting for reporting bias, although translational claims require independent experimental validation.

S. Arulsamy, Kiruthiga Natarajan, S. K. Krishnan et al. · 0 citations
Oct 2026

Evaluation of Murrayanine's Anticancer Potential in Breast Cancer: Integrative Computational, In Vitro, and Nanoparticle Delivery Approaches.

The experimental data suggest that Murrayanine delivered as SLNs is a promising preclinical candidate for breast cancer treatment, and an integrated use of computational and experimental approaches highlights the ability of natural product drug discovery to address breast cancer.

Yue Di, Xin-Cheng Hu, Jin-Dong Dai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.